Клініко-патогенетичні особливості поєднаного перебігу остеоартрозу та цукрового діабету 2-го типу

146. Lee Y.H. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis/ Y.H. Lee [et al.] // Rheumatol. Int. - 2010. - Vol. 30(3). - P. 357-363.

147. Lee, A.S. A current review of molecular mechanisms regarding osteoarthritis and pain / A.S. Lee, M.B. Ellman, D. Yan, J.S. Kroin [et al.] // Gene. - 2013. - Vol. 527. - P. 440-447.

148. Leeb B.F. Clinical efficiency and safety of diacerein in osteoarthritis - a review / B.F. Leeb // Eur Muscoskel Rev. - 2010. - Vol.31. - P.23-28.

149. Legendre F. Rhein, a diacerhein-derived metabolite, modulates the expression of matrix degrading enzymes and the cell proliferation of articular chondrocytes by inhibiting ERK and JNK-AP-1 dependent pathways. / F.Legendre, P.Bogdanowicz, G. Martin [et al.] // Clin Exp Rheumatol. - 2007. - Vol. 25. - P. 546-555.

150. Lementowski P.W. Obesity and osteoarthritis / Lementowski P.W., Zelicof S.B. // Am. J. Orthop. (Belle Mead N.J.). - 2008. - Vol. 37, № 3. - P. 148-151.

151. Levinger I. The effect of acute exercise on undercarboxylated osteocalcin in obese men. / I. Levinger, R. Zebaze, G. Jerums, D.L. Hare [et al.] // Osteoporosis International. - 2011. - Vol.22(5). - P.1621-1626.

152. Li J. RANK is the intrinsic hematopoieticcell surface receptor that controls osteoclastogenesis and regulation of bonemass and calcium metabolism / J. Li, I. Sarosi, X.Q. Yan [et al.] // Proc Natl Acad Sci USA. - 2000. - Vol. 97 (4). - P. 1566-1571.

153. Li X. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. / X. Li, P. Liu, W. Liu [et al.] // Nat Genet. - 2005. - Vol.37. - P.945-52.

154. Loeser R.F. Osteoarthritis: A Disease of the Joint as an Organ / R.F. Loeser, S.R. Goldrina, C.R. Scanzello [et al.] // Arthritis Rheum. - 2012. - Vol. 64 (6). - P. 1697-1707.

155. Louati K. Association between diabetes mellitus and osteoarthritis: a systematic literature review and meta-analysis. / K. Louati, F.Berenbaum, J. Sellam // Rheum&Muscculosk.Dis. - 2015- Vol. 1.Issue 1 - P.1-10.

156. Louthrenoo W. The efficacy, safety and carry-overeffect of diacerein in the treatment of painful kneeosteoarthritis: a randomised, double-blind, NSAIDcontrolled study. / W. Louthrenoo, S. Nilganuwong, S. Aksaranugraha [et al.] // Osteoarthritis Cartilage. - 2007. - Vol.15 (6). - P. 605-614.

157. Luyten F.P. Wnt-signaling and osteoarthritis. / F.P. Luyten, P. Tylzanowski, R.J. Lories // Bone. - 2009. - Vol.44. - P.522-527.

158. Luyten F.R. Contemporary concepts of inflammation, damage and repair in rheumatic diseases. / R.J. Lories, U. Verschueren [et al.] // Best Pract Res Clin Rheum. - 2006. - Vol.5. - P. 829-48.

159. Magliano M. Review Obesity and arthritis. / M.Magliano // Menopause International. - 2008. - Vol.14 (4). - P.149-154.

160. Magnusson K. Diabetes is associated with increased hand pain in erosive hand osteoarthritis - data from a population-based study / K.Magnusson, K.B.Hagen, N.Osterеs, L.Nordsletten [et al.] // Arthritis Care Res (Hoboken). - 2014. - Vol. 67(2)- P.187-195

161. Maheu E. Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study / E. Maheu, C. Cadet, M. Marty [et al.] // Ann. Rheum. Dis. - 2007. - Vol. 73 (2). - P. 376-384.

162. Maпmoun L. Effect of physical activity on calcium homeostasis and calciotropic hormones: a review. / L.Maпmoun, C.Sultan // Calcified Tissue International. - 2009. - Vol.85(4). - P.277-286

163. Mainard D. Role of leptin in the pathogenesis of osteoarthritis: a clinical and experimental study / D. Mainard, H. Dumont, N. Presle [et al.] // J Bone Joint Surg Br Proceedings. - 2008.-Vol. 90-B. - P. 254-255.

164. Manek Nisha J. The association of body mass index and osteoarthritis of the knee joint: an examination of genetic and environmental influences / J.Manek Nisha, D. Hart, T.D. Spector, J. MacGregor Alexander // Arthrit Rheum. - 2003. - Vol. 48 (4). - P. 1024-1029.

165. Marcu K.B. NF-kappaB signaling: multiple angles to target OA / K.B. Marcu, M. Otero, E. Olivotto, R.M. Borzi, M.B. Goldring // Curr Drug Targets. - 2010. - Vol. 11. - P. 599-613.

166. Martel-Pelletier J. Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review / J. Martel-Pelletier, S. Kwan Tat, J.-P. Pelletier // Osteoarthritis and Cartilage. - 2010. - Vol.18, Supp.1. - P.7-11.

167. Martel-Pelletier J., Lajeunesse D., Reboul P., Pelletier J.P. (2007) The role of subchondral bone in osteoarthritis, In: Sharma L., Berenbaum F, editors. (eds), Osteoarthritis: a companion to rheumatology, MosbyElsevier: Philadelphia, pp. 15-32

168. Mastbergen, S.C. Changes in subchondral bone early in the development of osteoarthritis / S.C. Mastbergen, F.P. Lafeber // Arthritis Rheum. - 2011. - Vol.63. - P. 2561-2563.

169. Matt C. McClain and Stephen Obesity, Inflammation, and the Potential Application of Pharmaconutrition Nutr / Matt C. Cave, Ryan T. Hurt, Thomas H. Frazier [et al.] // Clin Pract. - 2008. - Vol. 23 (1). - P.16-34.

170. McAlindon T.E. OARSI guidelines for the non-surgical management of knee osteoarthritis. / T.E. McAlindon, R.R. Bannuru, M.C. Sullivan et al. // Osteoarthritis and Cartilage/OARS, Osteoarthritis Research Society. - 2014. - Volume 22, Issue 3. - P. 363-388

171. McErlain, D.D. An in vivo investigation of the initiation and progression of subchondral cysts in a rodent model of secondary osteoarthritis. / D.D. McErlain, V. Ulici, M. Darling [et al.] // Arthritis Res Ther. - 2012. - Vol. 14. - R26.

172. Merlotti D. Mechanisms of impaired bone strength in type 1 and 2 diabetes. / D. Merlotti, L. Gennari, F. Dotta, D. Lauro [et al.] // Nutrition, Metabolism and Cardiovascular Diseases. - 2010. - Vol.20(9). - P.683-690.

173. Miazgowski T. Serum adiponectin, bone mineral density and bone turnover markersin post-menopausal women with newly diagnosed type 2 diabetes: a 12-month follow-up / T. Miazgowski, M. Noworyta-Zietara, K. Safranow [et al.] // Diabet Med, 2012. - Vol. 29 (1). - P.62-69.

174. Miller G.D. Inflammatory Biomarkers and Physical Function in Older, Obese Adults with Knee Pain and Self-Reported Osteoarthritis After Intensive Weight-Loss Therapy / G.D. Miller, B.J. Nicklas, R.F. Loeser // J Am Geriatr Soc. - 2008. - Vol.56:4. - P.644-651.

175. Monira Hussain S. Incidence of total knee and hip replacement for osteoarthritis in relation to the metabolic syndrome and its components: a prospective cohort study / S.Monira Hussain, Y. Wang, F.M. Cicuttini, J.A. Simpson [et al.] // Semin Arthritis Rheum. - 2014. - Vol. 43. - P. 429-436.

176. Movahed A. Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism / A. Movahed, B. Larijani, I. Nabipour, M. Kalantarhormozi [et al.] // J Bone Miner Metab. - 2012. - Vol. 30(6). - P.683-91.

177. Murshed M. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone / M. Murshed [et al.] // Genes. Dev. - 2005. - Vol. 19. - P. 1093 - 1104.

178. Nadeau K. A boost to the study of insulin secretion in children and adolescents Nadeau K., Zeitler P.S. // J Pediatr. - 2008 - Vol.152 (5). - P.603-4. doi: 10.1016/j.jpeds.2008.01.005

179. Nieves-Plaza M. Association of hand or knee osteoarthritis with diabetes mellitus in a population of Hispanics from Puerto Rico / M. Nieves-Plaza, L.E.Castro-Santana, Y.M.Font, A.M.Mayor, et al.] // J Clin Rheumatol. - 2013. - Vol.19. - P. 1-6.

180. Pacifici R. Role of T-cells in ovariectomy induced bone loss-revisited / R. Pacifici //J Bone Miner Res. - 2012. - Vol.27 (2). - P. 231-239.

181. Patti A. Endocrine Actions of Osteocalcin /Aurora Patti,* Luigi Gennari, Daniela Merlotti, Francesco Dotta, and Ranuccio Nuti // Int J Endocrinol. 2013. - 2013:846480. - doi:10.1155/2013/846480

182. Pavelka K. The efficacy and safety of Diacerhein in the treatment treatment of painful osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo-controlled study with primery end points at two months after the end of a three month treatment period. / K.Pavelka, T.Trc, K.Karpas [еt al.] // Arthr Rheum. - 2007. - Vol.56. - P.4055-4064.

183. Pereira D. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review / D. Pereira, D. Peleteiro, J. Araujo [et al.] // Osteoarthritis Cartilage. - 2011. - Vol.19 (11). - P.1270-85. doi: 10.1016/j.joca. 2011.08.009. Epub 2011 Aug 24.

184. Pincus T. Clinical evidence for osteoarthritis as an inflammatory disease. / T. Pincus // Cur Rheum Rep. - 2001. - Vol.3. - P.524-34.

185. Prasadam, I. ERK-1/2 and p38 in the regulation of hypertrophic changes of normal articular cartilage chondrocytes induced by osteoarthritic subchondral osteoblasts. / I.Prasadam, S.van Gennip, T. Friis, W. Shi [et al.] //Arthritis Rheum. - 2010. - Vol. 62. - P. 1349-1360.

186. Rahman M. Risk of Type 2 Diabetes among Osteoarthritis Patients in a Prospective Longitudinal Study / M. Rahman, J. Cibere, A. Anis, C. Goldsmith, J. Kopec // International Journal of Rheumatology. - 2014. - Article ID 620920. doi:10.1155/2014/620920

187. Ramakrishnan, P. Oxidative conditioning and treatment for osteoarthritis. in: Studies on Arthritis and Joint Disorders / P. Ramakrishnan, M. Brouillette, J. Martin // Humana Press. - 2013. - Chapter 17- P. 311-332

188. Reilly M.P. Plasma cytokines, metabolic syndrome, and atherosclerosis in humans / M.P. Reilly [et al.] // J of Investigative Medicine. - 2007. - Vol. 55, № 1. - P.26-35.

189. Ren K. Role of IL-1 beta during pain and inflammation / K. Ren, R. Torres // Brain Res Rev. - 2009. - Vol.60. - P. 57-64.

190. Rhouma M. Anti-inflammatory response of dietary vitamin E and its effects on pain and joint structures during early stages of surgically induced osteoarthritis in dogs ./ M. Rhouma, A. de Oliveira E. Warrak, E. Troncy [et al.] //Can J Vet Res. - 2013. - Vol.77(3). - P.191-198

191. Richette P. What is New on Osteoarthritis Front? / P. Richette, T. Funk-Brentano // Eur. Musculoskel. Rev. - 2010. - Vol. 5 (2). - P. 8-10.

192. Rodrigues A. Apolipoprotein E and undercaboxylated osteocalcin are associated with bone fragility but not with bone mineral density in osteoarthritis patients. / A. Rodrigues, J. Caetano-Lopes, A. Lopes [et al.] // Journal of Translational Medicine. - 2011. - 9(Suppl 2). - P.54 doi:10.1186/1479-5876-9-S2-P54

193. Roemer F.W. Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study / F.W.Roemer, A.Guermazi, D.T. Felson [et al.] // Ann. Rheum. Dis. - 2011. - Vol. 70 (10). - P. 1804-1809.

194. Roman-Blas J.A. Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes / J.A. Roman-Blas, D.G. Stokes, S.A. Jimenez // Osteoarthritis Cartilage. - 2007. - № 6. - P. 27.

195. Rosa S.C. Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage. / S.C.Rosa, J.Gonзalves, F.Judas, A.Mobasheri [et al.] // Arthritis Res Ther. - 2009. - Vol. 11. - P. 80

196. Rosenstock J. Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial. / J. Rosenstock, D.L. Lorber, L. Gnudi, C.P. Howard [et al.] // Lancet. - 2010. - Vol.26, 375(9733). - P.2244-53. doi: 10.1016/S0140-6736(10)60632-0.

197. Rydйn M. Tumour necrosis factor-б in human adipose tissue - from signalling mechanisms to clinical implications / M. Rydйn, P. Arner // Journal of Internal Medicine. - 2007. - Vol.262,№4. - P.431.

198. Saidak Z. Strontium signaling: Molecular mechanisms and therapeutic implications in osteoporosis. / Z. Saidak, P.J. Marie // Pharmacol Ther, 2012. - Vol. 136 (2). - P. 216-226.

199. Saltman D.C. Co-morbidity in general practice / D.C. Saltman, G.P. Sayer, S.D. Whicker // Postgraduate Med J. - 2005. - Vol.81. - P.474--480.

200. Samsell, L. Importance of android/gynoid fat ratio in predicting metabolic and cardiovascular disease risk in normal weight as well as overweight and obese children. / L.Samsell, M.Regier, C.Walton, L.Cottrell // J Obes. - 2014. - Article ID 846578. - 7 Pgs,2014 doi:10.1155/2014/846578

201. Sanchez C. Phenotypic characterization of osteoblasts from the sclerotic zones of osteoarthritic subchondral bone. / C. Sanchez, M.A. Deberg, A. Bellahcene [et al.] // Arthritis Rheum. - 2008. - Vol.58. - P. 442-455.

202. Sanchez C. Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes / C. Sanchez, M.A. Deberg, N. Piccardi [et al.] // Osteoarthritis and cartilage/OARS. Osteoarthritis Res Soc. - 2005. - Vol.13. - P. 988-997.

203. Santangelo K.S. Vivo reduction or blockade of interleukin-1в in primary osteoarthritis influences expression of mediators implicated in pathogenesis. / K.S. Santangelo, G.J. Nuovo, A.L. BertoneIn // Osteoarthritis and Cartilage. - 2012. - Vol.20, №12. - P.1610-1618;

204. Schett G. Diabetes Is an Independent Predictor for Severe Osteoarthritis / G. Schett [et al.] // Diabetes care. - 2013. - Volume 36. - P.403-409.

205. Schroder K. The inflammasomes / K. Schroder, J. Tschopp // Cell. - 2010. - Vol. 140. - P. 821-832.

206. Sharma L. Osteoarthritis: a companion to rheumatology. Philadelphia: Incidence and progression of osteoarthritis in women with unilateral knee disease in the general population: the effect of obesity / L. Sharma, F. Berenbaum // Ann. Rheum. Dis. - 2007. - Vol.53. - P. 565-568.

207. Shen Y. Postmenopausal women with osteoarthritis and osteoporosis show different ultrastructural characteristics of trabecular bone of the femoral head / Yun Shen, Zi-Ming Zhang, Sheng-Dan Jiang, Lei-Sheng Jiang [et al.] // BMC Musculoskeletal Disorders. - 2009. - Vol. 10. - doi:10.1186/1471-2474-10-35

208. Shikhman A.R. Cytokine regulation of facilitated glucose transport in human articular chondrocytes / A.R. Shikhman, D.C. Brinson, J.Valbracht, M.K. Lotz // J Immunol. - 2001. - Vol. 167. - P. 7001-7008.

209. Shoelson S.E. Inflammation and insulin resistance / S.E.Shoelson, J.Lee, A.B. Goldfine // J Clin. Invest. - 2006. - Vol. 116. - Р. 1793-1801.

210. Shu A. Bone structure andturnover in type 2 diabetes mellitus / A Shu., M.T. Yin, E.Stein [et al.] // Osteoporos Int. - 2012. - Vol. 23(2). - P.635-641

211. Skurk T. Relationship between adipocyte size and adipokine expression and secretion / T. Skurk, C. Alberti-Huber, C. Herder, H.J. Hauner // Clin Endocrinol Metab. - 2007. - Vol.92(3). - P.1023-33.

212. Sokolove J., Lepus C.M. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations // Ther. Adv. Musculoskelet. Dis. 2013. Vol. 5. № 2. P. 77-94.

213. Sowers M. Knee osteoarthritis in obese women with cardiometabolic clustering. / M.Sowers, C.A. Karvonen-Gutierrez, R.Palmieri-Smith, J.A. Jacobson [et al.] // Arthritis Rheum. - 2009. - Vol. 61. - P. 1328-1336.

214. Spector T.D. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. / T.D. Spector, P.G. Conaghan, J.C. Buckland-Wright [et al.] // Arthritis Res Ther. - 2005. - Vol. 7. - R625-R633.

215. Stannus O. Circulating levels of IL-6 and TNF-alpha are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults./ O. Stannus, G. Jones, F. Cicuttini [et al.] // Osteoarthritis Cartilage. - 2010. - Vol. 18. - P. 1441-1447.

216. Steinecker-Frohnwieser B. The disease modifying osteoarthritis drug diacerein is able to antagonize pro inflammatory state of chondrocytes under mild mechanical stimuli / B. Steinecker-Frohnwieser, L. Weigl, W. Kullich [et al.] // Osteoarthritis and Cartilage. - 2014. - Vol.22, №7. - P. 1044-1052

217. Stienstra R. Autophagy in adipose tissue and the beta cell: implications for obesity and diabetes / R.Stienstra, Y.Haim, Y.Riahi, M.Netea [et al.] // Diabetologia. - 2014. - Vol. 57. - P. 1505-1516.

218. Tatari H. The structure, physiology, and biomechanics of articular cartilage: injury and repair // Acta Orthop. Traumatol. Turc. 2007. Vol. 41. Suppl. 2. P. 1-5.

219. Tchernot A., Despers J.P. Pathophysiology of human visceral obesity: an update // Physiol. Rev. 2013. Vol. 93. № 1. P. 359-404.

220. Thomas Vangsness C. Human knee synovial fluid cytokines correlated with grade of knee osteoarthritis / C. Thomas Vangsness [et al.] // Bulletin of the NYU hospital of Joint Diseases. - 2011. - Vol. 2. - P. 122-127.

221. Toegel S. Phenotype-related differential alpha-2,6- or alpha-2,3-sialylation of glycoprotein N-glycans in human chondrocytes / S.Toegel, M.Pabst, S.Q. Wu, J.Grass [et al.] // Osteoarthr Cartil. - 2010. - Vol. 18. - P. 240-248.

222. Toncheva A. Inflammatory response in patients with active and inactive osteoarthritis / A. Toncheva [et al.] // Rheumatol. Int. - 2009. - Vol.29., № 10. - P. 1197-1203.

223. Upton A.R. The expression of RANKL and OPG in the various grades of osteoarthritic cartilage / A.R. Upton, C.A. Holding, A.A. Dharmapatn, D.R. Haynes // Rheumatol Int. - 2012. - Vol. 32(2). - P. 535-40.

224. van Sloten T.T. Peripheral neuropathy, decreased muscle strength and obesity are strongly associated with walking in persons with type 2 diabetes without manifest mobility limitations / T.T van Sloten, H.H.Savelberg, I.G. Duimel-Peeters [et al.] // Diabetes Res. Clin. Pract. - 2011. - Vol. 91. - P. 32-39.

225. Volpe C., The Production of Nitric Oxide, IL-6, and TNF-Alpha in Palmitate-Stimulated PBMNCs Is Enhanced through Hyperglycemia in Diabetes. / C. Volpe, L. Abreu, P. Gomes, R. Gonzaga [et al.] // Oxidative Medicine and Cellular Longevity. - 2014. - Article ID 479587. - P.12.

226. Wandel S. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis / S. Wandel et al. // BMJ. - 2010. - Vol.16. - P.341 (c4675. doi: 10.1136/bmj.c4675).

227. Wang X. Metabolic triggered inflammation in osteoarthritis /X. Wang, D. Hunter, J. Xu, C. Ding // Osteoarthritis and Cartilage.- 2015. - Vol.23, №1. - P.22-30.

228. Wang Y. Body weight at early and middle adulthood, weight gain and persistent overweight from early adulthood are predictors of the risk of total knee and hip replacement for osteoarthritis. / Y.Wang, A.E.Wluka, J.A.Simpson, G.G.Giles, [et al.] // Rheumatology (Oxford). - 2013. - Vol.52(6). - P.1033-1041

229. Wang Y. Relationship between body adiposity measures and risk of primary knee and hip replacement for osteoarthritis: a prospective cohort study / Y.Wang, J.A. Simpson, A.E. Wluka, A.J. Teichtahl [et al.] // Arthritis Res Ther. - 2009. - Vol. 11. - R31.

230. Wassilew G.I. The expression of proinflammatory cytokines and matrix metalloproteinases in the membranes of patients wishostearthritis compared with traumatic knee disorders / G.I. Wassilew [et al.] // Arthroscopy. - 2010. - № 26(8). - P. 1096-1104.

231. Wellen K.E. Inflammation, stress, and diabetes / K.E. Wellen, G.S. Hotamisligil // J Clin Invest. - 2005. - Vol.115 (5). - P. 1111-19.

232. Wildi I.M. Chondroitin sulfate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. / I.M. Wildi, J.P. Raynauld, J. Martel-Pelletier [et al.] //Ann Rheum Dis. - 2011. - Vol.70 (6). - P.982-989.

233. Winkler G. Molecular mechanisms and correlations of insulin resistance, obesity, and type 2 diabetes mellitus / G.Winkler, K. Cseh // Orv. Hetil. - 2009. - Vol. 150, № 17. - P. 771-780.

234. Yang, H. Oxidative stress and diabetes mellitus / H. Yang, X.Jin, C.W.Kei Lam, S.-K. Yan // Clin Chem Lab Med. - 2011. - Vol. 2011. - P. 1773-1782.

235. Yoshimura N. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study / N. Yoshimura, S. Muraki, H. Oka, S. Tanaka [et al.] // Osteoarthritis and Cartilage. - 2012. - Vol. 20, Issue 11. - P.1217-1226.

236. Yoshimura N. Association of knee osteoarthritis with the accumulation of metabolic risk factors such as overweight, hypertension, dyslipidemia, and impaired glucose tolerance in Japanese men and women: the ROAD study. / N. Yoshimura, S. Muraki, H. Oka, H. Kawaguchi [et al.] // J Rheumatol. - 2011. - Vol.38(5). - P.921-30. doi: 10.3899/jrheum.100569. Epub 2011 Feb 15. PMID: 21324967.

237. Zhang W. OARSI recommendations for the management of hip and knee osteoarthritis : part III: Changes in evidence following systematic cumulative update of research published through January 2009 / W. Zhang, G.Nuki, R.W. Moskowitz [et al.] // Osteoarth. Cartil. - 2010. - Vol. 18(4). - P. 476-499.

238. Zheng W.J. Efficacy and safety of diacerein in osteoarthritis of the knee: a randomized,multicenter, double-dummy, diclofenac-controlled trial in China, APLAR / W.J. Zheng, F.L. Tang, J. Li [et al.] // J. Rheumatology. - 2006. - Vol. 9(1). - P. 64-69.

239. Zhuo Q. Metabolic syndrome meets osteoarthritis / Q. Zhuo, W. Yang, J. Chen [et al.] // Nat. Rev. Rheumatol. - 2012. - Vol. 8. - P. 729-737.

ПЕРЕЛІК УМОВНИХ ПОЗНАЧЕНЬ

АГ - артеріальна гіпертензія

АТ - артеріальний тиск

АЛТ - аланінова амінотрансфераза

АСТ - аспарагінова амінотрансфераза

ВООЗ - Всесвітня організація охорони здоров'я

ГКН - глюкоза сироватки крові натщесерце

ЗХС - загальний холестерин

ІМТ - індекс маси тіла

ІР - інсулінорезистентність

ІЛ-1в - інтерлейкін-1в

ЛФ - лужна фосфатаза

МС - метаболічний синдром

МКХ - міжнародна класифікація хвороб

МРТ - магнітно-резонансна томографія

МФД - Міжнародна федерація діабету

ОА - остеоартроз

ОС - окружність стегон

ОТ - окружність талії

ОТ/ОС - співвідношення окружності талії до окружності стегон

СХК - субхондральна кістка

ТГ - тригліцериди

ФНП-б - фактор некрозу пухлин-б

ХС ЛПВЩ - холестерин ліпопротеїнів високої щільності

ХС ЛПДНЩ - холестерин ліпопротеїнів дуже низької щільності

ХС ЛПНЩ - холестерин ліпопротеїнів низької щільності

ЦД - цукровий діабет

ACR - американський коледж ревматологів

Сa - кальцій

НbА1с - глікозильований гемоглобін

IDF - міжнародна федерація діабета

Mg - магній

OARSI - міжнародна спільнота по вивченню остеоартроза

P - фосфор

Ro - рентгенологічне дослідження

Размещено на Allbest.ru

...